日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[Expression of Concern] Establishment and evaluation of a new highly metastatic tumor cell line 5a‑D‑Luc‑ZsGreen expressing both luciferase and green fluorescent protein

【关注事项】建立和评估一种新的高转移性肿瘤细胞系 5a-D-Luc-ZsGreen,该细胞系同时表达荧光素酶和绿色荧光蛋白

Sudo, Hitomi; Tsuji, Atsushi B; Sugyo, Aya; Takuwa, Hiroyuki; Masamoto, Kazuto; Tomita, Yutaka; Suzuki, Norihiro; Imamura, Takeshi; Koizumi, Mitsuru; Saga, Tsuneo

(191)Pt-labeled trithiol-Hoechst-PSMA: preliminary evaluation of conjugates designed for delivery to genomic DNA of PSMA-positive cancers

(191)Pt标记的三硫醇-Hoechst-PSMA:用于递送至PSMA阳性癌症基因组DNA的缀合物的初步评估

Obata, Honoka; Tsuji, Atsushi B; Feng, Yutian; Zheng, Yongxiang; Sugyo, Aya; Sudo, Hitomi; Kajiwara, Chie; Minegishi, Katsuyuki; Zhang, Ming-Rong; Zalutsky, Michael R

Evaluation of the Gly-Phe-Lys Linker to Reduce the Renal Radioactivity of a [(64)Cu]Cu-Labeled Multimeric cRGD Peptide

评估 Gly-Phe-Lys 连接子对降低 [(64)Cu]Cu 标记的多聚体 cRGD 肽肾脏放射性的影响

Jin, Zhao-Hui; Degardin, Mélissa; Furukawa, Takako; Uehara, Tomoya; Tsuji, Atsushi B; Suzuki, Hiroyuki; Wakizaka, Hidekatsu; Sugyo, Aya; Aung, Winn; Suzuki, Hisashi; Nagatsu, Kotaro; Zhang, Ming-Rong; Dumy, Pascal; Boturyn, Didier; Higashi, Tatsuya

Comparative Evaluation of Wavelength-Dependent Photodynamic Therapy Efficacy Using Representative Red and Near-Infrared Photosensitizers in a Single Tumor Model

在单一肿瘤模型中,利用代表性的红色和近红外光敏剂对波长依赖性光动力疗法的疗效进行比较评价

Aung, Winn; Tsuji, Atsushi B; Jin, Zhao-Hui; Sugyo, Aya; Kajiwara, Chie; Higashi, Tatsuya

The tyrosine kinase inhibitor nintedanib enhances the efficacy of 90 Y-labeled B5209B radioimmunotherapy targeting ROBO1 without increased toxicity in small-cell lung cancer xenograft mice

酪氨酸激酶抑制剂尼达尼布可增强靶向 ROBO1 的 90Y 标记 B5209B 放射免疫疗法在小细胞肺癌异种移植小鼠中的疗效,且不增加毒性。

Fujiwara, Kentaro; Tsuji, Atsushi B; Sudo, Hitomi; Sugyo, Aya; Hamakubo, Takao; Higashi, Tatsuya

Head-to-head comparison of three chelates reveals DOTAGA promising for (225) Ac labeling of anti-FZD10 antibody OTSA101

三种螯合物的直接比较表明,DOTAGA有望用于抗FZD10抗体OTSA101的(225)Ac标记。

Sudo, Hitomi; Tsuji, Atsushi B; Sugyo, Aya; Harada, Yosuke; Nagayama, Satoshi; Katagiri, Toyomasa; Nakamura, Yusuke; Higashi, Tatsuya

FZD10-targeted α-radioimmunotherapy with (225) Ac-labeled OTSA101 achieves complete remission in a synovial sarcoma model

使用 (225)Ac 标记的 OTSA101 进行 FZD10 靶向 α 放射免疫疗法,可在滑膜肉瘤模型中实现完全缓解。

Sudo, Hitomi; Tsuji, Atsushi B; Sugyo, Aya; Harada, Yosuke; Nagayama, Satoshi; Katagiri, Toyomasa; Nakamura, Yusuke; Higashi, Tatsuya

In vivo validation of the switch antibody concept: SPECT/CT imaging of the anti-CD137 switch antibody Sta-MB shows high uptake in tumors but low uptake in normal organs in human CD137 knock-in mice

体内验证转换抗体概念:SPECT/CT成像显示,抗CD137转换抗体Sta-MB在人CD137敲入小鼠的肿瘤中摄取量高,而在正常器官中摄取量低。

Sugyo, Aya; Tsuji, Atsushi B; Sudo, Hitomi; Narita, Yoshinori; Taniguchi, Kenji; Nemoto, Takayuki; Isomura, Fumihisa; Awaya, Norihiro; Kamata-Sakurai, Mika; Higashi, Tatsuya

The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3

天然硫糖脂衍生物SQAP可提高组织因子靶向放射免疫疗法在富含基质的胰腺癌模型BxPC-3中的治疗效果。

Takakusagi, Yoichi; Sugyo, Aya; Tsuji, Atsushi B; Sudo, Hitomi; Yasunaga, Masahiro; Matsumura, Yasuhiro; Sugawara, Fumio; Sakaguchi, Kengo; Higashi, Tatsuya

Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma

利用新型抗体NZ-16进行靶向足蛋白的α放射免疫疗法治疗恶性间皮瘤的临床前评估

Sudo, Hitomi; Tsuji, Atsushi B; Sugyo, Aya; Kaneko, Mika K; Kato, Yukinari; Nagatsu, Kotaro; Suzuki, Hisashi; Higashi, Tatsuya